Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Ondine Biomed (OBI) Share News

AIM WINNERS & LOSERS: Tracsis wins UK rail deal; Ondine optimistic

19th Feb 2025 11:03

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Wednesday. Read More

Ondine Biomedical shares slide as funding continues to be delayed

27th Jan 2025 11:04

(Alliance News) - Ondine Biomedical Inc on Monday said it expects its cash to last until the beginning of the fourth-quarter as it reported an equity investment from a leading US healthcare provider. Read More

AIM WINNERS & LOSERS: hVIVO wins deal; Good Energy backs buyout

27th Jan 2025 10:04

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Monday. Read More

LONDON MARKET MIDDAY: Uninspiring trade as no Santa rally for FTSE 100

30th Dec 2024 12:05

(Alliance News) - London's FTSE 100 was in the red midday Monday, eating into a year-to-date gain that already pales in comparison to counterparts state side. Read More

AIM WINNERS & LOSERS: Ondine Biomedical rises, Proton Power declines

30th Dec 2024 11:01

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Monday. Read More

Ondine Biomedical reports "exciting milestone" in US phase 3 trial

30th Dec 2024 09:51

(Alliance News) - Ondine Biomedical Inc on Monday said it has recruited and treated the first patient in its phase 3 clinical trial evaluating its non-antibiotic nasal photodisinfection technology. Read More

AIM WINNERS & LOSERS: Emmerson up as seeks compensation from Morocco

1st Nov 2024 10:58

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Friday. Read More

Ondine Biomedical shares climb as raises funds for US clinical study

1st Nov 2024 10:47

(Alliance News) - Ondine Biomedical Inc on Friday revealed a proposed fundraise as it looks to fund a phase 3 clinical study in the US. Read More

IN BRIEF: Ondine confirms Steriwave pilot at London hospital

23rd Oct 2024 10:30

Ondine Biomedical Inc - Vancouver-based company specialising in photodisinfection-based therapies - Announces King's College Hospital in London will run a pilot of its Steriwave technology later this year. Ondine says the pilot is part of a quality improvement initiative focused on preventing hospital-acquired infections. Steriwave is a light-activated antimicrobial treatment that eliminates infection-causing pathogens in a single five-minute treatment. Steriwave was added to the NHS supply chain back in June. Read More

Ondine Biomedical celebrates regulatory approval of Steriwave in UAE

18th Oct 2024 11:27

(Alliance News) - Ondine Biomedical Inc on Friday said it received approval to market Steriwave in the United Arab Emirates. Read More

EARNINGS: Katoro Gold pretax loss narrows; Ondine Biomedical sales up

30th Sep 2024 13:43

(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Monday and not separately reported by Alliance News: Read More

IN BRIEF: Ondine Biomedical inks research deal for Steriwave ICU use

25th Sep 2024 14:30

Ondine Biomedical Inc - Vancouver-based company specialising in photodisinfection-based therapies - Announces research collaboration with the Royal Columbian Hospital Foundation's Advancing Innovation in Medicine division. RCH Foundation is an independent charitable organisation that funds priority equipment, major projects and other RCH needs. Says research collaboration is in support of Steriwave use in intensive care units, and is investigating Steriwave's impact on infection prevention and patient outcomes in critical care settings starting with a 320-patient pilot. Ondine says there is potential for a subsequent multicentre trial with up to 2,000 patients depending on pilot results. Read More

IN BRIEF: Ondine Biomedical secures CAD5 million financing

24th Sep 2024 16:20

Ondine Biomedical Inc - Vancouver-based company specialising in photodisinfection-based therapies to prevent and treat a broad spectrum of infections - Announces it has agreed to private placement financing in exchange for common shares from a third-party private investor in Canada to support commercial growth. Ondine will issue 22.2 million new common shares, raising CAD5 million - around GBP2.8 million - at 12.5 pence per share. Read More

AIM WINNERS & LOSERS: Itim boosts revenue, Clontarf raises GBP450,000

24th Sep 2024 10:36

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Tuesday. Read More

IN BRIEF: Ondine says Steriwave use spreads across British Columbia

23rd Aug 2024 19:33

Ondine Biomedical Inc - Vancouver-based company specialising in photodisinfection-based therapies to prevent and treat a broad spectrum of infections - Says Steriwave nasal decolonization is now being used in all five of British Columbia's health authorities. Feels this signals Ondine's increasingly "strong presence" across the Canadian healthcare system. Read More

UK shareholder meetings calendar - next 7 days

21st Jun 2024 15:18

Read More

LONDON MARKET MIDDAY: Stocks decline as service sector growth slows

21st Jun 2024 12:08

(Alliance News) - Stocks in London nursed heavy falls at midday as a slowing in service sector activity offset brighter news from the UK's high streets. Read More

Ondine Biomedical celebrates Steriwave available via NHS Supply Chain

21st Jun 2024 10:29

(Alliance News) - Ondine Biomedical Inc on Friday said that its nasal photodisinfection Steriwave is now available through the NHS Supply Chain. Read More

AIM WINNERS & LOSERS: Ondine up on NHS boost; Arrow returns some gains

21st Jun 2024 10:22

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday. Read More

Ondine Biomedical loss narrows as revenue soars 88% in 2023

7th Jun 2024 14:23

(Alliance News) - Ondine Biomedical Inc on Friday said the company successfully made progress towards reaching profitability. Read More

FTSE 100 Latest
Value8,809.74
Change53.53